Skip to main content

Diabetes

  • Oramed calls oral insulin drug trial 'successful'

    JERUSALEM Oramed Pharmaceuticals has seen promising results from a clinical trial of an oral insulin for diabetes, the Israeli drug maker said.

     

    The company said its exploratory clinical trial of the oral insulin capsule ORMD-0801 was successful. The company is developing the capsule as a treatment for patients with uncontrolled Type 1 diabetes. The company also is developing the oral insulin as a treatment for Type 2 diabetes.

     

     

  • Kmart to host diabetes education day

    HOFFMAN ESTATES, Ill. — Kmart Pharmacy is hosting its semi-annual diabetes education day on Wednesday at Kmart locations nationwide.

    As part of its diabetes education day, Kmart is offering blood-glucose meter demonstrations; blood pressure, body mass index and memory screenings; and educational information on raising diabetes awareness to its pharmacy patients. According to the American Diabetes Association, more than 23 million people in the United States have diabetes, which accounts for about 8% of the population.

  • Artificial Life launches GluCoMo app for diabetics

    LOS ANGELES A leading provider of award-winning mobile 3G technology and applications recently launched a mobile app for diabetics.

  • Type 2 diabetes linked with cognitive impairments, study shows

    WASHINGTON A small study conducted by Canadian researchers found factors that may link Type 2 diabetes with such cognitive impairments as dementia.

    Older adults with diabetes who also have high blood pressure, walk slowly or lose their balance, or believe they’re in bad health, are more likely to have poorer cognitive functions than those without these problems, according to a new study conducted by researchers at the University of Alberta in Canada and published in the September issue of Neuropsychology

  • Pittsburgh Business Group on Health’s LivingMyLife program to expand

    PITTSBURGH The Pittsburgh Business Group on Health’s LivingMyLife program, which helps diabetes patients with disease management through the use of “coach pharmacists,” will soon do the same for those with other diseases, according to published reports.

     

    The Pittsburgh Tribune-Review reported Friday that LivingMyLife also would help patients with asthma and heart disease. The program, which began in 2006, allows patients to manage their disease with visits to pharmacies, mostly Giant Eagle, Kmart and some independents.

  • Lack of sleep may increase IFG risk, study finds

    NEW YORK Lack of beauty sleep may up one's risk of developing a condition that leads to diabetes and heart disease, a new study found.

X
This ad will auto-close in 10 seconds